NDC 36987-3418

Saltbush

Saltbush

Saltbush is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Atriplex Wrightii Pollen.

• Product ID: 36987-3418_c6c9737f-cac3-445a-b895-e2dacca18a0f
• NDC: 36987-3418
• Product Type: Human Prescription Drug
• Proprietary Name: Saltbush
• Generic Name: Saltbush
• Dosage Form: Injection, Solution
• Route of Administration: INTRADERMAL; SUBCUTANEOUS
• Marketing Start Date: 1972-08-29
• Marketing Category: BLA / BLA
• Application Number: BLA102192
• Labeler Name: Nelco Laboratories, Inc.
• Substance Name: ATRIPLEX WRIGHTII POLLEN
• Active Ingredient Strength: 0 g/mL
• Pharm Classes: Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 36987-3418-2

10 mL in 1 VIAL, MULTI-DOSE (36987-3418-2)

• Marketing Start Date: 1972-08-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 36987-3418-4 [36987341804]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-3418-3 [36987341803]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-3418-2 [36987341802]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-3418-1 [36987341801]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
ATRIPLEX WRIGHTII POLLEN	.05 g/mL

OpenFDA Data

• SPL SET ID: ccd1d7d8-c5de-4cdb-b1e7-a3b114394fd4
• Manufacturer:
  • Nelco Laboratories, Inc.
• UNII:
  • U2AI3H2J5Y
  • 92N6W6KO2G
  • 2A64U81OQ3
  • 68R9X9Y96X
  • 098LKX5NCN
  • 380W4HYR6N
  • YB1308W43O
  • 644CZ16IR5
  • BBO1IJ3ZIW
  • DO87T1U2CI
  • YI19RB8YFD
  • JQ87AA60GU
  • 6532U64A3X
  • 81GS97HVFO
  • RX18M46K8L
  • 86LWA5503I
  • 2MH135KC6G
  • 5W6JAI84OI
  • V825XJG64G
  • 1GH3WV23KH
  • 2QOF601J1M
  • WIB701MW2H
  • WQ3S5294XY
  • N52MIQ81ZW
  • O4AB4546TP
  • DNB59M1NVU
  • 26U0BU8G83
  • B67NF86HF0
  • 57KIJ4772H
  • ANT994T71D
  • KU1V1898XX
  • 13KFG30UBR
  • 73B14PX5FW
• RxNorm Concept Unique ID - RxCUI:
  • 851933
  • 852049
  • 851937
  • 852327
  • 852596
  • 897335
  • 852535
  • 995746
  • 852082
  • 897394
  • 852240
  • 897506
  • 897319
  • 851929
  • 852010
  • 851988
  • 896249
  • 852155
  • 851893
  • 852216
  • 851897
  • 852212
  • 852745
  • 851941
  • 852529
  • 852077
  • 852099
  • 897307
  • 852542
  • 852554
  • 895922
  • 852001
  • 852161
  • 852032
  • 851972
  • 852023
  • 995604

Pharmacological Class

• Non-Standardized Pollen Allergenic Extract [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Increased IgG Production [PE]
• Pollen [CS]
• Allergens [CS]

NDC Crossover Matching brand name "Saltbush" or generic name "Saltbush"

NDC	Brand Name	Generic Name
36987-3413	Saltbush	Saltbush
36987-3414	Saltbush	Saltbush
36987-3415	Saltbush	Saltbush
36987-3416	Saltbush	Saltbush
36987-3417	Saltbush	Saltbush
36987-3418	Saltbush	Saltbush
36987-3419	Saltbush	Saltbush
36987-3420	Saltbush	Saltbush